Skip to main content

Table 1 Clinical parameters in NMOSD patients according to response to MMF

From: Integrative analysis of purine metabolites and gut microbiota in patients with neuromyelitis optica spectrum disorders after mycophenolate mofetil treatment

Variables

EG (n = 23)

LEG (n = 11)

p value

Relapse times

0

2.00 ± 0.89

< 0.001

Age (years)

39.95 ± 12.20

47.45 ± 11.76

0.106

Gender

(male: female)

5:18

1:10

0.638

Follow-up time (months)

21.00 ± 14.34

37 ± 20.27

0.060

EDSS before MMF

4.00 ± 0.86

3.5 ± 1.06

0.228

EDSS after MMF

3.00 ± 1.06

4.0 ± 1.30

0.005